23Andme Ebit from 2010 to 2024

ME Stock  USD 3.23  0.08  2.54%   
23Andme Holding's EBIT is decreasing over the years with slightly volatile fluctuation. EBIT is expected to dwindle to about -337.4 M. During the period from 2010 to 2024 23Andme Holding EBIT annual values regression line had coefficient of variation of (26.00) and r-squared of  0.61. View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
-321.4 M
Current Value
-337.4 M
Quarterly Volatility
57.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 23Andme Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 23Andme Holding's main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.9 M, Interest Expense of 11.6 M or Selling General Administrative of 101.2 M, as well as many indicators such as Price To Sales Ratio of 23.98, Dividend Yield of 0.0 or PTB Ratio of 27.94. 23Andme financial statements analysis is a perfect complement when working with 23Andme Holding Valuation or Volatility modules.
  
Check out the analysis of 23Andme Holding Correlation against competitors.

Latest 23Andme Holding's Ebit Growth Pattern

Below is the plot of the Ebit of 23Andme Holding Co over the last few years. It is 23Andme Holding's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 23Andme Holding's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

23Andme Ebit Regression Statistics

Arithmetic Mean(222,624,587)
Coefficient Of Variation(26.00)
Mean Deviation46,782,994
Median(188,783,000)
Standard Deviation57,881,724
Sample Variance3350.3T
Range152.2M
R-Value(0.78)
Mean Square Error1400.2T
R-Squared0.61
Significance0.0006
Slope(10,124,506)
Total Sum of Squares46904.1T

23Andme Ebit History

2024-337.4 M
2023-321.4 M
2022-328.4 M
2021-254.2 M
2020-185.2 M
2019-213.8 M

Other Fundumenentals of 23Andme Holding

About 23Andme Holding Financial Statements

23Andme Holding stakeholders use historical fundamental indicators, such as 23Andme Holding's Ebit, to determine how well the company is positioned to perform in the future. Although 23Andme Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in 23Andme Holding's assets and liabilities are reflected in the revenues and expenses on 23Andme Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 23Andme Holding Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-321.4 M-337.4 M
EBITDA-291.9 M-306.5 M
Ebt Per Ebit 2.07  2.18 
Ebit Per Revenue(1.46)(1.54)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of 23Andme Holding Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(122.52)
Revenue Per Share
8.224
Quarterly Revenue Growth
(0.34)
Return On Assets
(0.26)
Return On Equity
(1.54)
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.